BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 24789362)

  • 21. Translational oncology toward benefiting cancer patients: the Sun Yat-sen University Cancer Center experience.
    Guerin M; Qian C; Zhong Q; Cui Q; Guo Y; Bei J; Shao J; Zhu X; Huang W; Wu J; Liu R; Liu Q; Wang J; Jia W; Zheng X; Zeng Y
    Sci China Life Sci; 2016 Oct; 59(10):1057-1062. PubMed ID: 23132500
    [No Abstract]   [Full Text] [Related]  

  • 22. Awaiting a new era of cancer immunotherapy.
    Hong CW; Zeng Q
    Cancer Res; 2012 Aug; 72(15):3715-9. PubMed ID: 22815525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future Clinical Trials: Genetically Driven Trials.
    Astsaturov I
    Surg Oncol Clin N Am; 2017 Oct; 26(4):791-797. PubMed ID: 28923231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated patient and tumor genetic testing for individualized cancer therapy.
    Hertz DL; McLeod HL
    Clin Pharmacol Ther; 2016 Feb; 99(2):143-6. PubMed ID: 26537014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Future of Precision Medicine in Oncology.
    Millner LM; Strotman LN
    Clin Lab Med; 2016 Sep; 36(3):557-73. PubMed ID: 27514468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt signalling in gynaecological cancers: A future target for personalised medicine?
    Ford CE; Henry C; Llamosas E; Djordjevic A; Hacker N
    Gynecol Oncol; 2016 Feb; 140(2):345-51. PubMed ID: 26432042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precision medicine in breast cancer.
    Naito Y; Urasaki T
    Chin Clin Oncol; 2018 Jun; 7(3):29. PubMed ID: 30056731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precision medicine in oncology: what is it exactly and where are we?
    Le Tourneau C; Kamal M; Bièche I
    Per Med; 2018 Sep; 15(5):351-353. PubMed ID: 30260312
    [No Abstract]   [Full Text] [Related]  

  • 30. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
    Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K; ;
    J Clin Oncol; 2006 Oct; 24(28):4642-60. PubMed ID: 17008706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward individualized treatment in urologic oncology.
    Rini BI
    Urol Oncol; 2015 Apr; 33(4):170. PubMed ID: 25661236
    [No Abstract]   [Full Text] [Related]  

  • 32. American Society of Clinical Oncology Developing First Clinical Trial.
    Brower V
    J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer prevention in the era of precision oncology.
    Brahme NN; Szabo E
    Clin Pharmacol Ther; 2017 May; 101(5):575-577. PubMed ID: 28032900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Targeted based therapies in metastatic breast cancer: future evolution].
    Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P
    Therapie; 2012; 67(6):491-503. PubMed ID: 23249575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer diagnostics: The journey from histomorphology to molecular profiling.
    Ahmed AA; Abedalthagafi M
    Oncotarget; 2016 Sep; 7(36):58696-58708. PubMed ID: 27509178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
    MacConaill LE; Lindeman NI; Rollins BJ
    JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
    [No Abstract]   [Full Text] [Related]  

  • 37. [Personalized medicine in oncology].
    Lörsch AM; Jung J; Lange S; Pfarr N; Mogler C; Illert AL
    Pathologie (Heidelb); 2024 May; 45(3):180-189. PubMed ID: 38568256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in medical oncology].
    Shi YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource.
    Kurnit KC; Bailey AM; Zeng J; Johnson AM; Shufean MA; Brusco L; Litzenburger BC; Sánchez NS; Khotskaya YB; Holla V; Simpson A; Mills GB; Mendelsohn J; Bernstam E; Shaw K; Meric-Bernstam F
    Cancer Res; 2017 Nov; 77(21):e123-e126. PubMed ID: 29092956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments and future perspectives of personalized oncology.
    Grüllich C; von Kalle C
    Onkologie; 2012; 35 Suppl 1():4-7. PubMed ID: 22286581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.